• Fri, September 9, 2022
David Amsellem Maintained (BHC) at Hold with Decreased Target to $6 on, Sep 9th, 2022
David Amsellem of Piper Sandler, Maintained "Bausch Health Companies Inc." (BHC) at Hold with Decreased Target from $7 to $6 on, Sep 9th, 2022.
David has made no other calls on BHC in the last 4 months.
There are 4 other peers that have a rating on BHC. Out of the 4 peers that are also analyzing BHC, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Douglas Miehm of "RBC Capital" Maintained at Hold with Increased Target to $8 on, Thursday, September 1st, 2022
- Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $8 on, Wednesday, August 10th, 2022
- Gregory Fraser of "Truist Securities" Downgraded from Strong Buy to Hold on, Friday, July 29th, 2022
- Chris Schott of "JP Morgan" Downgraded from Buy to Hold on, Friday, July 29th, 2022